Abstract
To the Editor—Yrjänäinen et al. [1] have demonstrated that mice infected with Borrelia burgdorferi the spirochetal agent of Lyme disease, may have persistent culture-proven infection despite appropriate antibiotic therapy when treated with the immune modulator anti–tumor necrosis factor–α [1]. Their study adds to the list of animal experiments that have demonstrated persistent infection despite “appropriate” short-course antibiotic therapy in hamsters [2], mice [3–5], dogs [6, 7], and horses [8]. Furthermore, immune modulation can induce persistent B. burgdorferi infection and tissue pathology over a period of months to years in a rhesus macaque model of chronic Lyme disease [9, 10]. Thus, the findings of Yrjänäinen et al. are consistent with the findings of these previous animal studies

This publication has 9 references indexed in Scilit: